Cargando…

High Dose Hypofractionated Proton Beam Therapy is a Safe and Feasible Treatment for Central Lung Cancer

BACKGROUND: There have been few reports about high total dose hypofractionated proton beam therapy for central lung cancer. The aim of this study was to examine retrospectively the safety and efficacy of high total dose hypofractionated proton beam therapy for central lung cancer. PATIENTS AND METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ono, Takashi, Yabuuchi, Tomonori, Nakamura, Tatsuya, Kimura, Kanako, Azami, Yusuke, Hirose, Katsumi, Suzuki, Motohisa, Wada, Hitoshi, Kikuchi, Yasuhiro, Nemoto, Kenji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter Open 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5611997/ https://www.ncbi.nlm.nih.gov/pubmed/28959169 http://dx.doi.org/10.1515/raon-2017-0023

Ejemplares similares

Proton beam therapy is a safe and feasible treatment for patients with second primary lung cancer after lung resection
por: Ono, Takashi, et al.
Publicado: (2018)

The clinical results of proton beam therapy in patients with idiopathic pulmonary fibrosis: a single center experience
por: Ono, Takashi, et al.
Publicado: (2016)

Clinical results of proton beam therapy for elderly patients with non-small cell lung cancer
por: Ono, Takashi, et al.
Publicado: (2018)

Clinical results of proton beam therapy for twenty older patients with esophageal cancer
por: Ono, Takashi, et al.
Publicado: (2015)

Proton Beam Therapy Combined with Intra-Arterial Infusion Chemotherapy for Stage IV Adenoid Cystic Carcinoma of the Base of the Tongue
por: Takayama, Kanako, et al.
Publicado: (2019)

Proton Beam Therapy in Combination with Intra-Arterial Infusion Chemotherapy for T4 Squamous Cell Carcinoma of the Maxillary Gingiva
por: Endo, Hiromasa, et al.
Publicado: (2018)

Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma
por: Makita, Chiyoko, et al.
Publicado: (2014)

Preliminary treatment results of proton beam therapy with chemoradiotherapy for stage I–III esophageal cancer
por: Takada, Akinori, et al.
Publicado: (2016)

Outcomes and Prognostic Factors for Locally Recurrent Rectal Cancer Treated With Proton Beam Therapy
por: Takagawa, Yoshiaki, et al.
Publicado: (2023)

Profile analysis of adverse events after boron neutron capture therapy for head and neck cancer: a sub-analysis of the JHN002 study
por: Hirose, Katsumi, et al.
Publicado: (2022)

Proton beam therapy is a safe and effective treatment in elderly patients with esophageal squamous cell carcinoma
por: Ono, Takashi, et al.
Publicado: (2020)

The Role of Hypofractionation in Proton Therapy
por: Santos, Alexandre, et al.
Publicado: (2022)

Effectiveness of proton beam therapy for liver oligometastatic recurrence in patients with postoperative esophagus cancer
por: Yamaguchi, Hisashi, et al.
Publicado: (2023)

Effect of anatomical change on dose distribution during radiotherapy for maxillary sinus carcinoma: passive scattering proton therapy versus volumetric-modulated arc therapy
por: Narita, Yuki, et al.
Publicado: (2019)

Clinical Efficacy of Hypofractionated Proton Beam Therapy for Intrahepatic Cholangiocarcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2022)

Proton Beam Therapy With Space-Making Surgery (Omental Plombage) for Oligorecurrent Liver Metastasis of Esophageal Adenocarcinoma
por: Ishikawa, Yojiro, et al.
Publicado: (2022)

The in-silico feasibility of dose escalated, hypofractionated radiotherapy for rectal cancer
por: Devlin, Lynsey, et al.
Publicado: (2022)

Long-term results of a phase II study of hypofractionated proton therapy for prostate cancer: moderate versus extreme hypofractionation
por: Ha, Boram, et al.
Publicado: (2019)

RT-03 POSTOPERATIVE CYBERKNIFE HYPOFRACTIONATED RADIOTHERAPY FOR THE ELDERLY PATIENTS WITH GLIOBLASTOMA
por: Tabei, Yusuke, et al.
Publicado: (2019)

Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2020)

In silico comparison of the dosimetric impacts of a greater omentum spacer for abdominal and pelvic tumors in carbon-ion, proton and photon radiotherapy
por: Yamada, Masayoshi, et al.
Publicado: (2019)

The Feasibility Study of Hypofractionated Radiotherapy with Regional Hyperthermia in Soft Tissue Sarcomas
por: Spałek, Mateusz Jacek, et al.
Publicado: (2021)

Clinical Results of Proton Beam Therapy for Esophageal Cancer: Multicenter Retrospective Study in Japan
por: Ono, Takashi, et al.
Publicado: (2019)

Acute toxicity and patient‐reported symptom score after conventional versus moderately hypofractionated proton therapy for prostate cancer
por: Iizumi, Takashi, et al.
Publicado: (2021)

Ultra-Hypofractionated Proton Therapy in Localized Prostate Cancer: Passive Scattering versus Intensity-Modulated Proton Therapy
por: Borowicz, Dorota Maria, et al.
Publicado: (2021)

Accelerated hypofractionated breast radiotherapy with simultaneous integrated boost: a feasibility study
por: Yadav, Budhi Singh, et al.
Publicado: (2022)

Definitive hypofractionated radiation therapy for early stage breast cancer: Dosimetric feasibility of stereotactic ablative radiotherapy and proton beam therapy for intact breast tumors
por: Lischalk, Jonathan W., et al.
Publicado: (2018)

Hypofractionated Proton Boost Combined with External Beam Radiotherapy for Treatment of Localized Prostate Cancer
por: Johansson, Silvia, et al.
Publicado: (2012)

The Role of Hypofractionated Radiation Therapy with Photons, Protons, and Heavy Ions for Treating Extracranial Lesions
por: Laine, Aaron Michael, et al.
Publicado: (2016)

Clinical Effectiveness of Hypofractionated Proton Beam Therapy for Liver Metastasis From Breast Cancer
por: Kim, Tae Hyun, et al.
Publicado: (2021)

Comparing Ultra-hypofractionated Proton versus Photon Therapy in Extremity Soft Tissue Sarcoma
por: Thomas, Rehema, et al.
Publicado: (2023)

Moderate hypofractionated radiotherapy is more effective and safe for localized prostate cancer patients: a meta-analysis
por: Cao, Ling, et al.
Publicado: (2016)

Mild Hypofractionated Radiation Therapy for Merkel Cell Carcinoma
por: Matsui, Toshiaki, et al.
Publicado: (2020)

Efficacy of chemotherapy and palliative hypofractionated radiotherapy for cats with nasal lymphoma
por: NAKAZAWA, Maho, et al.
Publicado: (2021)

Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative Group
por: Parzen, Jacob S., et al.
Publicado: (2020)

Comorbidity-Adjusted Survival in Early Stage Lung Cancer Patients Treated with Hypofractionated Proton Therapy
por: Do, Sharon Y., et al.
Publicado: (2010)

Hypofractionated high-energy proton-beam irradiation is an alternative treatment for WHO grade I meningiomas
por: Vlachogiannis, Pavlos, et al.
Publicado: (2017)

Normofractionated and moderately hypofractionated proton therapy: comparison of acute toxicity and early quality of life outcomes
por: Pelak, Maciej J., et al.
Publicado: (2022)

Hypofractionation: less is more?
por: Mariam, Neethu Billy Graham, et al.
Publicado: (2021)

Ion Prostate Irradiation (IPI) – a pilot study to establish the safety and feasibility of primary hypofractionated irradiation of the prostate with protons and carbon ions in a raster scan technique
por: Habl, Gregor, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_u2tk4ph05nh7pshv7uq1gjnpac